Debt Veränderung Datum
AbbVie USD 60.75B 269M 2023-09
Acorda Therapeutics USD 176.16M 4.67M 2023-06
Amgen USD 64.61B 4.15B 2023-12
Anika Therapeutics USD 132K 10K 2022-06
Arrowhead Research USD 263.06M 263.06M 2023-06
AstraZeneca USD 28.58B 1.26B 2023-09
BioCryst Pharmaceuticals USD 833.18M 13.88M 2023-09
Biogen USD 6.94B 348.2M 2023-12
Bristol-Myers Squibb USD 39.77B 2.17B 2023-12
Enanta Pharmaceuticals USD 1.42M 0 2023-09
Gilead Sciences USD 24.98B 264M 2023-09
GlaxoSmithKline GBP 20.84B 638M 2023-09
Halozyme Therapeutics USD 1.5B 1.63M 2023-12
Heron Therapeutics USD 149.44M 52K 2023-09
Immunic USD 0 0 2022-06
Incyte USD 32.6M 678K 2023-12
Insmed USD 1.18B 7.19M 2023-12
Ionis Pharmaceuticals USD 1.27B 14.67M 2023-12
J&J USD 29.92B 15.68B 2023-09
Ligand Pharmaceuticals USD 7K 76.83M 2023-12
Marinus Pharmaceuticals USD 72.48M 497K 2023-09
Merck USD 34.86B 2.05B 2023-09
Neurocrine Biosciences USD 169.9M 200K 2023-09
Novartis USD 210M 28.09B 2023-09
Novavax USD 222.11M 23.17M 2023-09
Pfizer USD 63.6B 1.74B 2023-09
PTC Therapeutics USD 2.12B 762.21M 2023-12
Roche Holding CHF 25.39B 35M 2023-06
Sarepta Therapeutics USD 1.24B 1.24M 2023-09
Vertex Pharmaceuticals USD 390.3M 13.8M 2023-09



Enanta Pharmaceuticals SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.